TriSalus Life Sciences (TLSI) Other Non-Current Assets (2022 - 2026)
TriSalus Life Sciences (TLSI) reported Other Non-Current Assets of $69000.0 for Q1 2026, down 83.73% on a YoY basis from $424000.0 in Q1 2025, and down 83.49% quarter-over-quarter from $418000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Other Non-Current Assets (2022 - 2026) Analysis & Trends
TriSalus Life Sciences has reported Other Non-Current Assets for 5 years, with the latest figure at $69000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 83.73% year-over-year to $69000.0; the trailing twelve-month figure through Mar 2026 stood at $69000.0 (down 83.73% YoY), and the FY2025 full-year result was $418000.0, down 1.18% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $69000.0, down from $418000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $466000.0 in Q4 2023, with the low at $69000.0 in Q1 2026.
- Historically, Other Non-Current Assets has averaged $387000.0 across 5 years, with a median of $421000.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets advanced 26.98% — and 2026, when it slumped 83.73%.
- TriSalus Life Sciences' Other Non-Current Assets stood at $367000.0 in 2022, then rose by 26.98% to $466000.0 in 2023, then decreased by 9.23% to $423000.0 in 2024, then decreased by 1.18% to $418000.0 in 2025, then sank by 83.49% to $69000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $69000.0 (Q1 2026), $418000.0 (Q4 2025), and $419000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | TriSalus Life Sciences | 209.25 Mn | 152.70 Mn | 7.67 Mn | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 419,000.00 |
| Mar 31, 2025 | 424,000.00 |
| Dec 31, 2024 | 423,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 424,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Dec 31, 2022 | 367,000.00 |